288 related articles for article (PubMed ID: 18180682)
1. Antimicrobial efficacy of prophylactic gatifloxacin 0.3% and moxifloxacin 0.5% in patients undergoing phacoemulsification surgery.
Bucci FA; Amico LM; Evans RE
Eye Contact Lens; 2008 Jan; 34(1):39-42. PubMed ID: 18180682
[TBL] [Abstract][Full Text] [Related]
2. Aqueous humour penetration of moxifloxocin and gatifloxacin eye drops in different dosing regimens before phacoemulsification surgery.
Güngör SG; Akova YA; Bozkurt A; Yasar Ü; Babaoğlu MÖ; Çetinkaya A; Çolak M
Br J Ophthalmol; 2011 Sep; 95(9):1272-5. PubMed ID: 21030410
[TBL] [Abstract][Full Text] [Related]
3. Fourth-generation fluoroquinolone penetration into the aqueous humor in humans.
McCulley JP; Caudle D; Aronowicz JD; Shine WE
Ophthalmology; 2006 Jun; 113(6):955-9. PubMed ID: 16603244
[TBL] [Abstract][Full Text] [Related]
4. Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients.
Kim DH; Stark WJ; O'Brien TP; Dick JD
Ophthalmology; 2005 Nov; 112(11):1992-6. PubMed ID: 16183125
[TBL] [Abstract][Full Text] [Related]
5. Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones: a retrospective observational case series.
Moshirfar M; Feiz V; Vitale AT; Wegelin JA; Basavanthappa S; Wolsey DH
Ophthalmology; 2007 Apr; 114(4):686-91. PubMed ID: 17184840
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of fourth-generation fluoroquinolones on epithelial healing after photorefractive keratectomy.
Shin JH; Lee HB; Park HY
Cornea; 2010 Nov; 29(11):1236-40. PubMed ID: 20697276
[TBL] [Abstract][Full Text] [Related]
7. Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty.
Holland EJ; Lane SS; Kim T; Raizman M; Dunn S
Cornea; 2008 Apr; 27(3):314-9. PubMed ID: 18362660
[TBL] [Abstract][Full Text] [Related]
8. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given by different methods before cataract surgery.
Ong-Tone L
J Cataract Refract Surg; 2007 Jan; 33(1):59-62. PubMed ID: 17189794
[TBL] [Abstract][Full Text] [Related]
9. Comparison of corneal and aqueous humor penetration of moxifloxacin, gatifloxacin and levofloxacin during keratoplasty.
Fukuda M; Yamada M; Kinoshita S; Inatomi T; Ohashi Y; Uno T; Shimazaki J; Satake Y; Maeda N; Hori Y; Nishida K; Kubota A; Nakazawa T; Shimomura Y
Adv Ther; 2012 Apr; 29(4):339-49. PubMed ID: 22529026
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 1: aqueous concentration of moxifloxacin.
Vasavada AR; Gajjar D; Raj SM; Vasavada V; Vasavada V
J Cataract Refract Surg; 2008 Aug; 34(8):1379-82. PubMed ID: 18655991
[TBL] [Abstract][Full Text] [Related]
11. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given in different concentrations in a wick before cataract surgery.
Ong-Tone L
J Cataract Refract Surg; 2008 May; 34(5):819-22. PubMed ID: 18471639
[TBL] [Abstract][Full Text] [Related]
12. Preoperative topical moxifloxacin 0.5% and povidone-iodine 5.0% versus povidone-iodine 5.0% alone to reduce bacterial colonization in the conjunctival sac.
Halachmi-Eyal O; Lang Y; Keness Y; Miron D
J Cataract Refract Surg; 2009 Dec; 35(12):2109-14. PubMed ID: 19969216
[TBL] [Abstract][Full Text] [Related]
13. Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing.
Levine JM; Noecker RJ; Lane LC; Herrygers L; Nix D; Snyder RW
J Cataract Refract Surg; 2004 Oct; 30(10):2177-82. PubMed ID: 15474833
[TBL] [Abstract][Full Text] [Related]
14. Ocular penetration of moxifloxacin 0.5% and gatifloxacin 0.3% ophthalmic solutions into the aqueous humor following topical administration prior to routine cataract surgery.
Kim DH; Stark WJ; O'Brien TP
Curr Med Res Opin; 2005 Jan; 21(1):93-4. PubMed ID: 15881479
[TBL] [Abstract][Full Text] [Related]
15. One-day application of topical moxifloxacin 0.5% to select for fluoroquinolone-resistant coagulase-negative Staphylococcus.
He L; Ta CN; Miño de Kaspar H
J Cataract Refract Surg; 2009 Oct; 35(10):1715-8. PubMed ID: 19781465
[TBL] [Abstract][Full Text] [Related]
16. The impact of short-term topical gatifloxacin and moxifloxacin on bacterial injection after hypodermic needle passage through human conjunctiva.
Pettey JH; Mifflin MD; Kamae K; McEntire MW; Pettey DH; Callegan MC; Brown H; Olson RJ
J Ocul Pharmacol Ther; 2013 Jun; 29(5):450-5. PubMed ID: 23425429
[TBL] [Abstract][Full Text] [Related]
17. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor.
Solomon R; Donnenfeld ED; Perry HD; Snyder RW; Nedrud C; Stein J; Bloom A
Ophthalmology; 2005 Mar; 112(3):466-9. PubMed ID: 15745775
[TBL] [Abstract][Full Text] [Related]
18. Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones.
Callegan MC; Novosad BD; Ramadan RT; Wiskur B; Moyer AL
Adv Ther; 2009 Apr; 26(4):447-54. PubMed ID: 19381523
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 2: residual conjunctival flora.
Vasavada AR; Gajjar D; Raj SM; Vasavada V; Vasavada V
J Cataract Refract Surg; 2008 Aug; 34(8):1383-8. PubMed ID: 18655992
[TBL] [Abstract][Full Text] [Related]
20. A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections.
Moss JM; Sanislo SR; Ta CN
Ophthalmology; 2009 Aug; 116(8):1498-501. PubMed ID: 19501409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
